How a new drug will improve quality of life for patients, and could reduce emergency admissions resulting from sickle cell crises
Thousands of patients with sickle cell disease in England are to have access to a ‘revolutionary’ treatment for sickle cell disease over the next three years.
Nursing Standard. 37, 3, 73-74. doi: 10.7748/ns.37.3.73.s23
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
